Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Blepharospasm
80%
Parkinson's Disease
72%
Telemedicine
66%
Movement Disorders
63%
Parkinson's Progression Markers Initiative
41%
Dystonia
41%
Motor Features
39%
Alpha-synuclein (α-syn)
39%
COVID-19
39%
Hyperkinetic Movement Disorders
39%
Parkinson Patients
29%
Telemedicine Utilization
24%
Age of Onset
22%
Motor Symptoms
22%
Spasm
22%
Analysis Cluster
22%
Focal Dystonia
21%
Integrated Staging Systems
21%
Segmental Dystonia
21%
Healthy Controls
19%
Volition
19%
Fellowship Training
19%
MR-guided
19%
Intraoperative Magnetic Resonance Imaging (iMRI)
19%
Single-center Experience
19%
Dopamine Dysregulation Syndrome
19%
Impulse Control Disorders
19%
Psychotic Features
19%
Disease Course
19%
Diagnostic Criteria
19%
Spinocerebellar Ataxia Type 3 (SCA3)
19%
International multicenter Study
19%
Dyskinesia
19%
Educational Attainment
19%
Functional Neurosurgery
19%
Factor Analysis
19%
Factor Clustering
19%
Sex Differences
19%
Neurological Care
19%
Disease Stage
19%
Isolated Dystonia
19%
Strabismus
19%
Mutation Data
19%
Idiopathic Parkinson's Disease
19%
Neuroimaging
19%
Chain Level
19%
Spectrum Disorder
19%
Gait
19%
Single-photon Emission Computed Tomography (SPECT)
19%
Age-matched
19%
Medicine and Dentistry
Stereotypic Movement Disorder
100%
Parkinson's Disease
99%
Telemedicine
73%
Diseases
47%
COVID-19
45%
Synuclein
23%
Alpha Synuclein
23%
Clinician
19%
Intraoperative MRI
19%
Functional Neurosurgery
19%
Parkinsonism
19%
Stiff Person Syndrome
19%
Adjuvant Therapy
19%
Spectrum Disorder
19%
Clostridium Botulinum Type A
19%
Spinocerebellar Ataxia
19%
Strabismus
19%
Diplopia
19%
Dyskinesia
19%
Impulse Control Disorder
19%
Cognition
19%
Dopamine Dysregulation Syndrome
19%
Sex Differences
19%
Cross Sectional Study
19%
Awareness
12%
Status Dystonicus
9%
Neuroleptic Malignant Syndrome
9%
Serotonin Syndrome
9%
Chorea Minor
9%
Laboratory Test
9%
High-Risk Population
9%
Catatonia
9%
Treatment Modality
9%
Dystonia
9%
Deep Brain Stimulation
9%
Hyperpyrexia
9%
Quality of Life
8%
Oscillopsia
8%
Binocular Convergence
8%
Synucleinopathies
7%
Health Care Cost
7%
Neurologic Examination
6%
Social Distancing
6%
Injection
6%
Functional Disease
6%
Disability
6%
Disease Exacerbation
6%
Psychosis
5%
Disease Duration
5%
4-Aminopyridine
5%